BeStock  
Stocks › Biotechnology › NVCT

Nuvectis Pharma NVCT

US equityMarket cap rank #3552Biotechnology
$20.29 +$0.26 (+1.30%)
Market closed · Oct 8, 5:40 am ET · Last extended-hours $20.29 0.00%
Open$19.67
Prev close$20.03
Day range$19.67 – $20.72
Volume121.1K
Market cap$662.35M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readLeaning bearish

2 bullish · 5 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-6.0%BearishTrading below the 20-day average of $21.59
Price vs 50-day average-7.0%BearishTrading below the 50-day average of $21.81
Price vs 200-day average+48.5%BullishTrading above the 200-day average of $13.66
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)43.6BearishMomentum leans negative
MACD (12,26,9)-0.44BearishMACD line is below its signal line
Bollinger band position19%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$21.59-6.0%
50-day SMA$21.81-7.0%
200-day SMA$13.66+48.5%

Recent price levels

LevelPrice
20-day high$24.24
20-day low$19.55
60-day high$25.94
60-day low$17.89
Upper Bollinger band$23.70
Lower Bollinger band$19.47

The 50-day average is currently 59.7% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility62.9%
Average true range7.41% of price
Max drawdown (1y)-36.8%
Volume (10d vs 90d)0.65x

Discussion

No comments yet — be the first to weigh in on NVCT.

Leave a comment

Scroll to Top